Patrick Johnson
Präsident bei Sydnexis, Inc.
Profil
Patrick T.
Johnson is currently the Director at Aviceda Therapeutics, Inc. and the President at Sydnexis, Inc. He previously worked as the VP-Development & Director-Cell Biology at Chimeros, Inc. He received his doctorate degree from the University of California, Santa Barbara in 2000.
Aktive Positionen von Patrick Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
Sydnexis, Inc.
 Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA. | Präsident | 01.01.2017 |
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 16.05.2023 |
Ehemalige bekannte Positionen von Patrick Johnson
| Unternehmen | Position | Ende |
|---|---|---|
Chimeros, Inc.
 Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Chimeros, Inc. develops novel therapies for cancer treatment. It focuses on the development of novel targeted treatments while generating immediate revenues from licensing platform rights and development contracts. Chimeros was founded in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Patrick Johnson
| University of California, Santa Barbara | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Chimeros, Inc.
Chimeros, Inc. Pharmaceuticals: MajorHealth Technology Chimeros, Inc. develops novel therapies for cancer treatment. It focuses on the development of novel targeted treatments while generating immediate revenues from licensing platform rights and development contracts. Chimeros was founded in 2004 and is headquartered in San Diego, CA. | Health Technology |
Sydnexis, Inc.
Sydnexis, Inc. Pharmaceuticals: MajorHealth Technology Sydnexis, Inc. engages in the production of ophthalmic pharmaceutical products. The company was founded by Gregory Isaac Ostrow in 2014 and is headquartered in San Diego, CA. | Health Technology |
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
